Therapeutic effectiveness of iodine-131 MIBG metastases of a nonsecreting paraganglioma

Journal Article · Wed Nov 30 23:00:00 EST 1988 · J. Nucl. Med.; (United States)

OSTI ID:6609401

Baulieu, J L; Guilloteau, D; Baulieu, F; Le Floch, O; Chambon, C; Pourcelot, L; Besnard, J C

This case report describes the treatment of the bone metastases of a nonfunctioning sympathetic paraganglioma, with ( T I)MIBG. After primary tumor excision and unsuccessful external radiotherapy, the patient received three therapeutic doses of ( T I)MIBG, resulting in a reduction of the number and volume of metastases, and an improvement of the general condition. At 3 yr following ( T I)MIBG therapy, the patient remained in remission. ( T I)MIBG appears to be an efficient and safe agent for treating malignant sympathetic paraganglioma.

• Research Organization: Departement de Cancerologie, Tours (France)
• OSTI ID: 6609401
• Journal Information: J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 29:12; ISSN JNMEA
• Country of Publication: United States
• Language: English

Related Subjects

550604* -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
AUTONOMIC NERVOUS SYSTEM
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
DAYS LIVING RADIOISOTOPES
DISEASES
GLIOMAS
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
ISOTOPES
MEDICINE
METASTASES
NEOPLASMS
NERVOUS SYSTEM
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PATIENTS
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
SKELETON
THERAPY